Neuroone Medical Technologies (NMTC) Convertible Debt (2017 - 2020)

Neuroone Medical Technologies has disclosed Convertible Debt across 4 years of filings, most recently posting $1.0 million for Q3 2020.

• Quarterly Convertible Debt changed N/A year-over-year to $1.0 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $1.0 million (changed N/A YoY) and the FY2020 annual result came in at $1.0 million, changed N/A from the prior year.
• Convertible Debt fell to $1.0 million in Q3 2020, from $6.7 million in the prior quarter.
• Across five years, Convertible Debt topped out at $6.7 million in Q2 2020 and bottomed at $1.0 million in Q3 2020.
• The 4-year median for Convertible Debt is $2.1 million (2018), against an average of $3.0 million.
• Year-over-year, Convertible Debt dropped 23.54% in 2018 and soared 213.2% in 2019.
• Neuroone Medical Technologies' Convertible Debt stood at $2.2 million in 2017, then dropped by 23.54% to $1.7 million in 2018, then soared by 213.2% to $5.2 million in 2019, then plunged by 80.6% to $1.0 million in 2020.
• According to Business Quant data, Convertible Debt over the past three periods registered $1.0 million, $6.7 million, and $4.9 million for Q3 2020, Q2 2020, and Q1 2020 respectively.